Get the Stockscreener App
1.12
2.61%
-0.03
After Hours:
1.12
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Forecast
The Sonnet Biotherapeutics Holdings Inc (SONN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $344.31, representing a +30,642% increase from the current price of $1.12. The highest analyst price target is $342.58, and the lowest is $346.04.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SONN Price Target
Average 314.05
(+27,940% Upside)
Is Sonnet Biotherapeutics Holdings Inc (SONN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.34 | Neutral |
| STOCH(9,6) | 18.65 | Buy |
| STOCHRSI(14) | 9.2657 | Buy |
| MACD(12,26) | -0.0295 | Buy |
| ADX(14) | 11.42 | Neutral |
| William %R | -94.11 | Buy |
| CCI(14) | -71.06 | Neutral |
Buy: 4
Sell: 0
Neutral: 3
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.1778
Sell
|
1.1693
Sell
|
| MA20 |
1.1715
Sell
|
1.1896
Sell
|
| MA50 |
1.2582
Sell
|
1.2651
Sell
|
| MA100 |
1.365
Sell
|
1.6306
Sell
|
| MA200 |
2.6441
Sell
|
3.4374
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SONN could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on SONN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.34 indicates that SONN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.65 indicates that SONN is oversold. This indicates that SONN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.2657 indicates that SONN is oversold. This suggests that SONN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.42 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -71.06 indicates that SONN is still oversold but not to an extreme extent.
Long-term SONN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sonnet Biotherapeutics Holdings Inc financial reports and earnings history, Sonnet Biotherapeutics Holdings Inc (SONN) stock could reach $597.87 by 2030, $340.73 by 2040 and $1,132.18 by 2050. See the projected annual prices until 2050 of the Sonnet Biotherapeutics Holdings Inc stock below:
- Sonnet Biotherapeutics Holdings Inc (SONN) is expected to reach an average price of $98.66 in 2035, with a high prediction of $112.44 and a low estimate of $98.76. This indicates an $8,709% rise from the last recorded price of $1.12.
- Sonnet Biotherapeutics Holdings Inc (SONN) stock is projected to chart a bullish course in 2040, with an average price target of $325.37, representing an $28,951% surge from its current level. The forecast ranges from a conservative $325.39 to a sky-high $340.73.
- Our analysts predict Sonnet Biotherapeutics Holdings Inc (SONN) to jump 58,804% by 2045, soaring from $659.86 to an average price of $659.73, potentially reaching $677.73. While $659.86 is the low estimate, the potential upside is significant.
- Sonnet Biotherapeutics Holdings Inc (SONN) stock is expected to climb by 2050, reaching an average of $1,104.22, a $98,491% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,132.18 and $1,106.74, respectively, highlighting the market's uncertainty.
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Year by Year Forecast
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2025
Sonnet Biotherapeutics Holdings Inc Stock (SONN) is expected to reach an average price of $271.58 in 2025, with a high prediction of $342.58 and a low estimate of $200.59. This indicates an +24,149% rise from the last recorded price of $1.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $344.42 | $346.04 | $342.58 | +30,651% |
| August, 2025 | $342.85 | $342.05 | $340.37 | +30,512% |
| September, 2025 | $338.77 | $339.05 | $339.73 | +30,147% |
| October, 2025 | $340.81 | $340.99 | $341.07 | +30,329% |
| November, 2025 | $332.38 | $334.06 | $336.43 | +29,577% |
| December, 2025 | $322.38 | $323.68 | $326.32 | +28,684% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2026
The predicted value for Sonnet Biotherapeutics Holdings Inc (SONN) in 2026 is set at an average of $291.36. Estimates vary from a peak of $320.66 to a trough of $262.06, indicating an +25,914% surge from the present price of $1.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $316.90 | $320.54 | $320.66 | +28,194% |
| February, 2026 | $313.08 | $312.29 | $313.50 | +27,853% |
| March, 2026 | $305.09 | $305.37 | $311.09 | +27,140% |
| April, 2026 | $290.05 | $291.59 | $298.47 | +25,797% |
| May, 2026 | $287.78 | $290.58 | $293.33 | +25,595% |
| June, 2026 | $285.10 | $285.52 | $286.93 | +25,356% |
| July, 2026 | $286.02 | $284.84 | $284.62 | +25,437% |
| August, 2026 | $278.58 | $280.68 | $282.76 | +24,773% |
| September, 2026 | $274.31 | $273.51 | $276.24 | +24,392% |
| October, 2026 | $270.93 | $271.63 | $272.31 | +24,090% |
| November, 2026 | $269.23 | $270.82 | $271.47 | +23,938% |
| December, 2026 | $261.80 | $262.06 | $267.84 | +23,275% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sonnet Biotherapeutics Holdings Inc (SONN) is $218.17, with a high forecast of $259.46 and a low forecast of $176.88. This indicates an +19,380% increase from the last price of $1.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $254.81 | $254.86 | $259.46 | +22,651% |
| February, 2027 | $247.79 | $248.33 | $252.30 | +22,024% |
| March, 2027 | $241.33 | $241.89 | $245.70 | +21,448% |
| April, 2027 | $236.13 | $236.30 | $239.33 | +20,983% |
| May, 2027 | $229.71 | $229.95 | $234.17 | +20,410% |
| June, 2027 | $221.43 | $221.48 | $227.85 | +19,671% |
| July, 2027 | $213.40 | $213.74 | $219.49 | +18,953% |
| August, 2027 | $207.32 | $207.51 | $211.34 | +18,411% |
| September, 2027 | $199.46 | $199.68 | $205.33 | +17,709% |
| October, 2027 | $192.44 | $193.10 | $197.74 | +17,082% |
| November, 2027 | $185.42 | $185.79 | $190.44 | +16,455% |
| December, 2027 | $176.63 | $176.88 | $183.21 | +15,671% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2028
In 2028, Sonnet Biotherapeutics Holdings Inc (SONN) is projected to reach an average price of $132.84, with a high projection of $174.82 and a low estimate of $90.86. This indicates an +11,760% rise from the last price of $1.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $170.94 | $171.12 | $174.82 | +15,163% |
| February, 2028 | $165.57 | $165.63 | $169.13 | +14,683% |
| March, 2028 | $156.51 | $157.08 | $163.67 | +13,874% |
| April, 2028 | $150.56 | $150.59 | $153.72 | +13,343% |
| May, 2028 | $141.85 | $142.04 | $148.78 | +12,565% |
| June, 2028 | $134.95 | $134.99 | $140.08 | +11,949% |
| July, 2028 | $128.22 | $128.28 | $133.16 | +11,348% |
| August, 2028 | $119.94 | $119.94 | $126.49 | +10,609% |
| September, 2028 | $113.37 | $113.39 | $118.17 | +10,022% |
| October, 2028 | $106.57 | $106.60 | $111.58 | +9,416% |
| November, 2028 | $97.71 | $97.79 | $104.84 | +8,624% |
| December, 2028 | $90.84 | $90.86 | $95.91 | +8,011% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2029
The 2029 price forecast for Sonnet Biotherapeutics Holdings Inc Stock (SONN) is $45.45 on average, with a high prediction of $89.06 and a low estimate of $1.8339. This represents an +3,958% increase from the previous price of $1.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $82.39 | $82.42 | $89.06 | +7,257% |
| February, 2029 | $75.55 | $75.58 | $80.61 | +6,646% |
| March, 2029 | $65.36 | $65.46 | $73.82 | +5,736% |
| April, 2029 | $59.76 | $59.90 | $63.57 | +5,236% |
| May, 2029 | $52.29 | $52.29 | $57.75 | +4,569% |
| June, 2029 | $45.14 | $45.20 | $50.30 | +3,930% |
| July, 2029 | $37.97 | $38.23 | $43.17 | +3,290% |
| August, 2029 | $29.65 | $29.65 | $36.19 | +2,547% |
| September, 2029 | $22.45 | $22.67 | $27.89 | +1,905% |
| October, 2029 | $13.48 | $13.67 | $20.27 | +1,103% |
| November, 2029 | $6.916 | $7.086 | $11.67 | +517.50% |
| December, 2029 | $505.88 | $1.8339 | $58.32 | +45,068% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2030
Sonnet Biotherapeutics Holdings Inc Stock (SONN) is expected to reach an average price of $673.19 in 2030, with a high forecast of $723.82 and a low forecast of $622.56. This signifies an +60,006% surge from the last price of $1.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $616.07 | $622.56 | $597.87 | +54,907% |
| February, 2030 | $704.23 | $634.67 | $638.71 | +62,777% |
| March, 2030 | $694.10 | $693.70 | $679.54 | +61,873% |
| April, 2030 | $749.50 | $723.42 | $723.82 | +66,819% |
| May, 2030 | $677.69 | $699.53 | $716.93 | +60,408% |
| June, 2030 | $663.92 | $659.89 | $649.36 | +59,179% |
| July, 2030 | $654.00 | $635.40 | $645.92 | +58,293% |
| August, 2030 | $687.55 | $686.95 | $676.63 | +61,288% |
| September, 2030 | $651.95 | $670.15 | $669.95 | +58,109% |
| October, 2030 | $645.66 | $637.78 | $631.10 | +57,548% |
| November, 2030 | $708.33 | $667.70 | $653.73 | +63,144% |
| December, 2030 | $761.91 | $712.37 | $694.57 | +67,927% |
1.11%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):